RARE
Ultragenyx
15.50$
+1.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -120.2% | -65.9% | -175.2% | -52.3% | -48.0% | -48.2% | -119.5% | -65.0% | -57.2% | -48.2% | -144.9% | -45.3% | -67.7% | |
| 7.3% | 6.5% | 8.1% | 6.0% | 6.3% | 5.5% | 6.5% | -7.1% | 5.4% | 4.2% | 5.9% | 3.7% | 4.7% | |
| 35.6% | 26.5% | 33.9% | 26.8% | 29.8% | 24.4% | 28.7% | 23.1% | 23.1% | 18.0% | 22.1% | 15.9% | 19.3% | |
| 2.9% | 11.7% | -51.5% | 11.1% | 22.1% | 13.8% | -40.7% | -13.1% | 34.3% | 0.3% | -37.5% | -13.6% | -3.4% | |
| 3.8% | 1.3% | 12.1% | 3.1% | 1.2% | 0.4% | 11.7% | 7.5% | 0.8% | 0.5% | 0.7% | 0.5% | 0.6% | |
| 65.6% | -84.0% | 86.8% | 41.2% | -197.5% | 62.3% | 86.1% | 42.7% | 73.3% | -34.9% | -36.0% | 20.6% | 5.6% | |
| – | – | -0.1% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 25.7% | 259.5% | -0.1% | 261.8% | 8.0% | 1.9% | 0.1% | 50.2% | 0.0% | 190.4% | – | 1.4% | – | |
| -29.6% | 110.5% | -89.2% | 250.2% | -236.6% | 14.5% | -32.3% | 29.7% | 16.3% | 107.1% | -184.6% | -22.9% | -7.3% | |
| -124.0% | -67.1% | -187.4% | -55.4% | -49.2% | -48.6% | -131.2% | -57.5% | -58.0% | -48.7% | -145.6% | -45.8% | -68.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.